SD 36 is primarily used in research and development within the field of medicinal chemistry. It serves as a key intermediate in the synthesis of various biologically active compounds, particularly those targeting specific enzymes or receptors involved in disease pathways. Its application is significant in the development of potential therapeutic agents, especially in oncology, where it may be utilized to create molecules that inhibit the growth of cancer cells. Additionally, SD 36 is explored in the study of neurodegenerative diseases, as it can be modified to interact with proteins implicated in these conditions. Its role in drug discovery underscores its importance in advancing new treatments for complex diseases.